title: Role of ultrasound screening for gallbladder disease in pretransplant patients.
abstract: There is no uniform data regarding prophylactic cholecystectomy in patients undergoing renal transplantation with gallbladder disease. Data analyses suggest that posttransplant patients on cyclosporine have a higher incidence of gallbladder calcifications compared with nonimmunosuppressed patients. Laparoscopic cholecystectomy is a relatively safe procedure in modern-day surgery. Taking these facts into consideration, we attempted to compare risks and complications associated with gallbladder disease and eventual cholecystectomy in pretransplant versus posttransplant patients. Between June 1999 and December 2005, 210 renal transplants were performed at our institution. One hundred four patients who had transplants before April 2003 were not screened for gallbladder disease and nine of these patients developed gallbladder disease. These patients form our control group. One hundred six patients who had transplants after April 2003 had pretransplant screening for gallbladder disease and 11 patients were identified with gallbladder disease. These patients form our study group. Nine patients who developed gallbladder disease after renal transplant underwent laparoscopic cholecystectomy with three resulting morbidities (33%), two graft losses (22%), and one mortality (11%). There was one mortality (11%) in this group. One patient in the study group died of acute gallstone pancreatitis. Of the 11 patients who were found to have gallbladder disease on screening, nine patients underwent laparoscopic cholecystectomy with one morbidity and no mortality or graft loss. Given the relative rarity of the critical events in this study (morbidity, mortality, and graft loss), the definitive statistical value of prescreening for gallbladder disease cannot be established. However, our results are suggestive of clinical value and thus we tentatively recommend ultrasound screening for gallbladder disease for all pretransplant patients and laparoscopic cholecystectomy for those identified to have gallbladder disease.
authors.affiliation: Department of Transplant and General Surgery, Geisinger Medical Center, Danville, Pennsylvania, USA. drmmeka@yahoo.com
authors.forename: Madhavi
authors.initials: M
authors.lastname: Meka
authors.forename: Santosh
authors.initials: S
authors.lastname: Potdar
authors.forename: Peter
authors.initials: P
authors.lastname: Benotti
authors.forename: J Edward
authors.initials: JE
authors.lastname: Hartle
authors.forename: Christopher
authors.initials: C
authors.lastname: Senkowski
mesh_terms: D017081:Cholecystectomy, Laparoscopic; D015331:Cohort Studies; D005705:Gallbladder Diseases / Q000000981:diagnostic imaging* / Q000453:epidemiology* / Q000601:surgery; D006801:Humans; D015994:Incidence; D007674:Kidney Diseases / Q000150:complications / Q000000981:diagnostic imaging / Q000601:surgery; D016030:Kidney Transplantation / Q000009:adverse effects; D017063:Outcome Assessment, Health Care; D012189:Retrospective Studies; D018570:Risk Assessment; D014463:Ultrasonography